Sequence-, time- and dose-dependent synergism of methotrexate and 6-mercaptopurine in malignant human T-lymphoblasts
- 1 October 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (20) , 3549-3555
- https://doi.org/10.1016/0006-2952(86)90625-8
Abstract
No abstract availableThis publication has 35 references indexed in Scilit:
- Cancer chemotherapy: Progress and expectations, 1984Cancer, 1984
- Surface morphology and membrane phenotype of cultured human leukemia-lymphoma cells: A scanning electron microscopic study of 36 cell linesCancer, 1983
- Enhancement of 6-thioguanine cytotoxic activity with methotrexateBiochemical and Biophysical Research Communications, 1982
- Effect of de novo purine synthesis inhibitors on 5-fluorouracil metabolism and cytotoxicityBiochemical Pharmacology, 1981
- Enhanced 5-Fluorouracil Nucleotide Formation After Methotrexate Administration: Explanation for Drug SynergismScience, 1979
- The ninth annual david karnofsky lecture.Treatment of acute lymphocytic leukemiaCancer, 1979
- Acute lymphoblastic leukemia: TreatmentCancer, 1978
- The Effect of 6-Mercaptopurine on the Duration of Steroid-induced Remissions in Acute Leukemia: A Model for Evaluation of Other Potentially Useful TherapyBlood, 1963
- Studies of Sequential and Combination Antimetabolite Therapy in Acute Leukemia: 6-Mercaptopurine and MethotrexateBlood, 1961
- Temporary Remissions in Acute Leukemia in Children Produced by Folic Acid Antagonist, 4-Aminopteroyl-Glutamic Acid (Aminopterin)New England Journal of Medicine, 1948